NIH-funded research R01 grant

Comprehensive protein detectors for the human proteome

Official title: Generation of comprehensive protein affinity reagents for the human proteome

Funded at California Institute of Technology · NIH-11405549 · Data updated 2026-11-12

A big new project to create many highly specific protein-binding tools (nanobodies) so scientists can reliably study most human proteins.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCalifornia Institute of Technology
NIH-funded
Lab location1 site (Pasadena, United States)
Project startSeptember 1, 2026
Project endAugust 31, 2031
Funding year2026
Award (this year)$1,119,634
NIH project number1R01CA325352-01
Project IDNIH-11405549 on NIH RePORTER

Who could benefit from this research

Could help

Researchers and clinicians studying any human disease could benefit from improved protein detection reagents to advance diagnostics and treatments.

Less likely to help

Direct patient benefit may be limited until translated into diagnostics or therapies; initial work is laboratory-based.

What this research studies

This project aims to build a scalable platform to generate and validate nanobodies that bind to a wide range of human proteins. It proposes a novel RAMEN approach using split-and-pool barcoding to ensure both large scale and high specificity. By providing validated reagents for many proteins, it could streamline diagnostic and therapeutic development and advance basic biology. The work will involve protein targets, assay development, and rigorous validation to ensure reproducibility across studies.

Why it matters

Potential benefit: If successful, patients could benefit from faster development of precise diagnostics and targeted therapies driven by better protein detection tools.

How similar studies have gone: Previous efforts improved antibodies but struggled with scale and specificity; this project proposes a novel, scalable solution that is still being tested.

Where this research is happening

  • California Institute of Technology
    Pasadena, United States
    Active

Researchers

  • Principal investigator: Guttman, Mitchell — California Institute of Technology
  • Study coordinator: Guttman, Mitchell

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.